Phantom Neuro Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Series B
- (Upcoming)
- Latest Deal Amount
-
$30M
- Investors
-
21
Phantom Neuro General Information
Description
Operator of a neurotechnology company intended to bridge the gap between modern-day robotics and individuals with limb differences. The company's machine control system maximizes the potential of robotic orthopedics in real-world environments by leveraging neuroscience and artificial intelligence, enabling patients with limb deficits to regain control over their lives.
Contact Information
Website
www.phantomneuro.comCorporate Office
- 105 West 8th Street
- Austin, TX 78701
- United States
Corporate Office
- 105 West 8th Street
- Austin, TX 78701
- United States
Phantom Neuro Timeline
Phantom Neuro Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series B) | $30M | Upcoming | Generating Revenue | |||
| 7. Later Stage VC (Series A) | 21-Nov-2025 | Completed | Generating Revenue | |||
| 6. Grant | 10-Mar-2025 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 02-Apr-2024 | Completed | Startup | |||
| 4. Seed Round | 03-Nov-2022 | Completed | Startup | |||
| 3. Accelerator/Incubator | 27-Apr-2022 | Completed | Startup | |||
| 2. Seed Round | 25-Mar-2022 | $3.26M | $3.26M | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2020 | Completed | Startup |
Phantom Neuro Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 8,398,653 | $0.000010 | $0.71 | $0.71 | 1x | $0.71 | 16.81% | |
| Seed | 5,534,801 | $0.000010 | $0.59 | $0.59 | 1x | $0.59 | 11.08% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Phantom Neuro Comparisons
Industry
Financing
Details
Phantom Neuro Competitors (5)
One of Phantom Neuro’s 5 competitors is Precision Neuroscience, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Precision Neuroscience | Venture Capital-Backed | New York, NY | ||||
| Blackrock Neurotech | Venture Capital-Backed | Salt Lake City, UT | ||||
| Neuralink | Venture Capital-Backed | Fremont, CA | ||||
| EMOTIV | Venture Capital-Backed | San Francisco, CA | ||||
| Neurable | Venture Capital-Backed | Boston, MA |
Phantom Neuro Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Phantom Neuro Patents
Phantom Neuro Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260157680-A1 | Implantable sensor strand | Pending | 17-Apr-2024 | ||
| EP-4794642-A1 | Prosthetic communication controller | Pending | 21-Dec-2023 | ||
| WO-2025136850-A1 | Prosthetic communication controller | Inactive | 21-Dec-2023 | ||
| US-20250088987-A1 | Synchronizing implantable electronics | Pending | 07-Sep-2023 | ||
| AU-2023413106-A1 | Methods and systems for prosthesis control | Pending | 22-Dec-2022 | A61F2/72 |
Phantom Neuro Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Phantom Neuro Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Actual VC | Venture Capital | Minority | ||
| Brown Advisory | Asset Manager | Minority | ||
| Crosscourt Ventures | Venture Capital | Minority | ||
| E1 Ventures | Venture Capital | Minority | ||
| Gaingels | Venture Capital | Minority |
Phantom Neuro FAQs
-
When was Phantom Neuro founded?
Phantom Neuro was founded in 2020.
-
Where is Phantom Neuro headquartered?
Phantom Neuro is headquartered in Austin, TX.
-
What is the size of Phantom Neuro?
Phantom Neuro has 18 total employees.
-
What industry is Phantom Neuro in?
Phantom Neuro’s primary industry is Therapeutic Devices.
-
Is Phantom Neuro a private or public company?
Phantom Neuro is a Private company.
-
What is Phantom Neuro’s current revenue?
The current revenue for Phantom Neuro is .
-
How much funding has Phantom Neuro raised over time?
Phantom Neuro has raised $28.5M.
-
Who are Phantom Neuro’s investors?
Actual VC, Brown Advisory, Crosscourt Ventures, E1 Ventures, and Gaingels are 5 of 21 investors who have invested in Phantom Neuro.
-
Who are Phantom Neuro’s competitors?
Precision Neuroscience, Blackrock Neurotech, Neuralink, EMOTIV, and Neurable are competitors of Phantom Neuro.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
